Physician profile
Robert Giulio Trasolini
NPI 1235496159
$20,154.10
in general payments reported to CMS, 2019-2025
17 companies · $4,747 in 2025
The $4,747 reported for 2025 was more than what 80% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,413 · 2020: $905 · 2021: $191 · 2022: $7,227 · 2023: $2,014 · 2024: $2,657 · 2025: $4,747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,694 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Travel and Lodging: $2,131 · Consulting Fee: $2,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,693.77 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Travel and Lodging | $2,131.22 |
| Consulting Fee | $2,092.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $6,678.53 | 2019-2025 | |
| Smith+Nephew, INC. | $3,315.79 | 2020-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Q-Fix |
| Gotham Surgical Solutions & Devices, INC. | $2,196.19 | 2019-2022 | |
| Medical Device Business Services, INC. | $2,092.50 | 2024 | |
| Encore Medical, LP | $1,655.89 | 2023 | Djo Surgical |
| Polaris Technology Solutions LLC | $1,161.42 | 2023-2025 | |
| Creo Medical INC. | $990.63 | 2022 | |
| Arcuro Medical INC | $977.20 | 2024-2025 | Superball, Superball |
| Linvatec Corporation | $462.48 | 2022-2023 | Biobrace 23mm, Allograft Tissue, Hall Power |
| Depuy Synthes Sales INC. | $400.29 | 2019-2024 | Inhance, Va-Lcp |
| Ferring Pharmaceuticals INC. | $46.04 | 2022-2025 | Euflexxa |
| Zimmer Biomet Holdings, INC. | $40.62 | 2023 | Samples Biologics |
| Horizon Therapeutics Plc | $40.41 | 2022 | |
| Sanara Medtech INC. | $32.50 | 2025 | Celleraterx |
| Vericel Corporation | $32.39 | 2025 | Maci |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $18.20 | 2024 | Durolane |
| Medtronic, INC. | $13.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Trasolini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.